Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HSPH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CSGALNACT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
DYX1C1-CCPG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAD51D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GDE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP4K3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TM7SF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBTB10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSC22D1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAMPT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AP3M2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBED8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KMT2E - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDK14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on